5 Most Shorted Stocks That Are Loved By Analysts

In this piece, we will take a look at the five most shorted stocks that are loved by analysts. If you want to skip our introduction to short selling, then jump ahead to 15 Most Shorted Stocks That Are Loved By Analysts.

5. Dragonfly Energy Holdings Corp. (NASDAQ:DFLI)

Short Interest Percentage: 12.15%

Average Share Price Target: $4.83

Share Price Upside: 198%

Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) is a battery manufacturer that sells batteries for ships, vehicles, and other equipment. The firm’s second quarter earnings results saw its revenue and gross profit drop while its net loss widened.

Seven out of the 910 hedge funds part of Insider Monkey’s Q2 2023 database had invested in Dragonfly Energy Holdings Corp. (NASDAQ:DFLI).

4. Zynex, Inc. (NASDAQ:ZYXI)

Short Interest Percentage: 28.29%

Average Share Price Target: $24

Share Price Upside: 212%

Zynex, Inc. (NASDAQ:ZYXI) is a medical equipment manufacturer that provides products for pain management. The firm announced in August 2023 that one million patients are now using its devices, and it has also beaten analyst EPS estimates in all four of its latest quarters.

As of June 2023, ten out of the 910 hedge funds part of Insider Monkey’s research had held a stake in the firm. Out of these, Zynex, Inc. (NASDAQ:ZYXI)’s biggest shareholder is Israel Englander’s Millennium Management since it owns 445,664 shares that are worth $4.2 million.

3. BioVie Inc. (NASDAQ:BIVI)

Short Interest Percentage: 9.51%

Average Share Price Target: $11.5

Share Price Upside: 241%

BioVie Inc. (NASDAQ:BIVI) is a biotechnology company developing treatments for Alzheimer’s disease, Parkinson’s disease, and other ailments. The firm’s second quarter earnings marked a turnaround of sorts, as it was the first quarter after the last three in which the firm had beaten analyst EPS estimates.

Insider Monkey took a look at 910 hedge fund portfolios and discovered five BioVie Inc. (NASDAQ:BIVI) investors during 2023’s second quarter. Neil Shahrestani’s Ikarian Capital is the company’s largest investor since it owns $1.9 million worth of shares.

2. Microvast Holdings, Inc. (NASDAQ:MVST)

Short Interest Percentage: 19.68%

Average Share Price Target: $8

Share Price Upside: 385%

Microvast Holdings, Inc. (NASDAQ:MVSt) develops and sells batteries for cars and other vehicles. Oppenheimer kept an Outperform rating for the shares in August 2023 and the firm beat its analyst EPS estimates for its second quarter.

After digging through 910 hedge fund portfolios for this year’s June quarter, Insider Monkey found 13 had bought Microvast Holdings, Inc. (NASDAQ:MVST)’s shares.

1. Bionano Genomics, Inc. (NASDAQ:BNGO)

Short Interest Percentage: 11.78%

Average Share Price Target: $20.2

Share Price Upside: 556%

Bionano Genomics, Inc. (NASDAQ:BNGO) is a medical technology company that enables researchers to conduct genomic research. The firm’s shares dipped in August after it announced that its CFO would leave the firm in September.

Eight out of the 910 hedge funds part of Insider Monkey’s Q2 2023 research had bought Bionano Genomics, Inc. (NASDAQ:BNGO)’s shares. Out of these, the biggest hedge fund shareholder is Israel Englander’s Millennium Management through its $2 million investment.

Disclosure: None.  You can also take a look at 11 Most Undervalued Bank Stocks To Buy According To Wall Street Analysts and Buffett Stock Portfolio: Warren Buffett’s Recent Buys.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter